Myositis Journey E29: Physical Therapy and Milton

[@meif3888]

❤ so happy for ur improvement. Your story give me strengh. Tks Kevin

[@laurenfernandez7189]

This is great news. Keeping you and the family in our prayers. - love your fellow myositis friends on the other side of FL

[@wanderingmusic38]

Thanks for the kind words. Do you have myositis too or one of your family members?

[@foblivio]

Great news Kevin!

[@wanderingmusic38]

Things are on the right track!

[@albertlai536]

Glad to see you doing better.

[@wanderingmusic38]

Thank you! I too and glad :)

[@MrWaynevflores]

That's nice. Very good. I think you are doing well. All the best.

[@wanderingmusic38]

Thank you!

[@JoeDaddyo]

You really are looking a lot improved. Add oil!

[@wanderingmusic38]

I try I try. Stacy would like to me to not gain much more weight before getting stronger ;)

[@Lovuss-o]

“Don’t forget to have a protein shake at the end of the therapy; it will help.”

[@wanderingmusic38]

thanks for the suggestion. I ordered some to take on therapy days!

[@Lovuss-o]

Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR-T cell therapy Edited by Lawrence Steinman, Stanford University, Stanford, CA; received September 19, 2023; accepted December 26, 2023 Evaluate the Safety & Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy UCI Specialty Area: Rheumatology Principal Investigator: Tahseen Mozaffar Official Title: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Active Idiopathic Inflammatory Myopathy A Study On: Idiopathic Inflammatory Myopathies Myositis